New Alzheimer's drug tested for safety in first human study
NCT ID NCT05551741
First seen Nov 05, 2025 · Last updated May 25, 2026 · Updated 30 times
Summary
This early-stage study tested a new drug called IBC-Ab002 in 40 people with early Alzheimer's disease. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo through an IV. The study focused on side effects and changes in lab tests, not on whether the drug improves symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barzilai Medical Center
Ashkelon, Israel
-
Brain Research Center
Amsterdam, Netherlands
-
Dementia Research Centre, National Hospital for Neurology and Neurosurgery
London, United Kingdom
-
King's College London - Institute of Psychiatry, Psychology & Neuroscience (IoPPN)
London, SE5 8AF, United Kingdom
-
RICE - Research Institute for the Care of Older People
Bath, BA1 3NG, United Kingdom
-
Rabin Medical Center
Petah Tikva, Israel
-
Sheba Medical Center
Ramat Gan, Israel
-
Sheffield teaching Hospitals NHS Trust
London, United Kingdom
-
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
-
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom
Conditions
Explore the condition pages connected to this study.